rxstat › Classes › Angiotensin Ii Antagonists, Combinations

Angiotensin Ii Antagonists, Combinations: shortage status in Canada

7 of the 9 angiotensin ii antagonists, combinations rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Amlodipine Telmisartan (Twynsta) Partial shortage 2 of 6 reported products affected Hydrochlorothiazide Candesartan Cilexetil (Atacand Plus) Partial shortage 4 of 21 reported products affected · est. return Aug 31, 2026 Hydrochlorothiazide Losartan (Hyzaar) Partial shortage 2 of 35 reported products affected Hydrochlorothiazide Valsartan Partial shortage 5 of 27 reported products affected · est. return Jul 31, 2026 Irbesartan Hydrochlorothiazide (Avalide) Partial shortage 14 of 35 reported products affected · est. return Mar 3, 2027 Olmesartan Medoxomil Hydrochlorothiazide (Olmetec Plus) Partial shortage 6 of 24 reported products affected Telmisartan Hydrochlorothiazide (Micardis Plus) Partial shortage 3 of 23 reported products affected Chlorthalidone Azilsartan Medoxomil (Edarbyclor) No current shortage Hydrochlorothiazide Eprosartan (Teveten Plus) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.